169 related articles for article (PubMed ID: 37783481)
1. European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors.
Joneborg U; Bergamini A; Wallin E; Mangili G; Solheim O; Marquina G; Casado A; Rokkones E; Coulter J; Lok CAR; van Trommel N; Amant F; Bolze PA; Sehouli J; Han S; Kridelka F; Goffin F; Pautier P; Ray-Coquard I; Seckl M
Int J Gynecol Cancer; 2023 Oct; 33(10):1621-1626. PubMed ID: 37783481
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers.
Naessens C; Laloze J; Leobon S; Gauthier T; Lacorre A; Monteil J; Venat L; Deluche E
Future Oncol; 2023 Apr; 19(13):897-908. PubMed ID: 37232140
[TBL] [Abstract][Full Text] [Related]
4. ESHRE guideline: endometriosis.
Becker CM; Bokor A; Heikinheimo O; Horne A; Jansen F; Kiesel L; King K; Kvaskoff M; Nap A; Petersen K; Saridogan E; Tomassetti C; van Hanegem N; Vulliemoz N; Vermeulen N;
Hum Reprod Open; 2022; 2022(2):hoac009. PubMed ID: 35350465
[TBL] [Abstract][Full Text] [Related]
5. Networking for ovarian rare tumors: a significant breakthrough improving disease management.
Chiannilkulchai N; Pautier P; Genestie C; Bats AS; Vacher-Lavenu MC; Devouassoux-Shisheboran M; Treilleux I; Floquet A; Croce S; Ferron G; Mery E; Pomel C; Penault-Llorca F; Lefeuvre-Plesse C; Henno S; Leblanc E; Lemaire AS; Averous G; Kurtz JE; Ray-Coquard I
Ann Oncol; 2017 Jun; 28(6):1274-1279. PubMed ID: 28398524
[TBL] [Abstract][Full Text] [Related]
6. Function, information, and contributions: An evaluation of national multidisciplinary team meetings for rare cancers.
Rosell L; Wihl J; Hagberg O; Ohlsson B; Nilbert M
Rare Tumors; 2019; 11():2036361319841696. PubMed ID: 31105919
[TBL] [Abstract][Full Text] [Related]
7. Guideline No. 408: Management of Gestational Trophoblastic Diseases.
Eiriksson L; Dean E; Sebastianelli A; Salvador S; Comeau R; Jang JH; Bouchard-Fortier G; Osborne R; Sauthier P
J Obstet Gynaecol Can; 2021 Jan; 43(1):91-105.e1. PubMed ID: 33384141
[TBL] [Abstract][Full Text] [Related]
8. Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.
Kuroki L; Stuckey A; Hirway P; Raker CA; Bandera CA; DiSilvestro PA; Granai CO; Legare RD; Sakr BJ; Dizon DS
Gynecol Oncol; 2010 Mar; 116(3):295-300. PubMed ID: 20042225
[TBL] [Abstract][Full Text] [Related]
9. Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.
Blay JY; Casali P; Ray-Coquard I; Seckl MJ; Gietema J; de Herder WW; Caplin M; Klümpen HJ; Glehen O; Wyrwicz L; Peeters R; Licitra L; Girard N; Piperno-Neumann S; Kapiteijn E; Idbaih A; Franceschi E; Trama A; Frezza AM; Hohenberger P; Hindi N; Martin-Broto J; Schell J; Rogasik M; Lejeune S; Oliver K; de Lorenzo F; Weinman A
Lancet Reg Health Eur; 2024 Apr; 39():100861. PubMed ID: 38384730
[TBL] [Abstract][Full Text] [Related]
10. Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project.
Juan Ribelles A; Berlanga P; Schreier G; Nitzlnader M; Brunmair B; Castel V; Essiaf S; Cañete A; Ladenstein R
Clin Transl Oncol; 2018 Aug; 20(8):1046-1052. PubMed ID: 29313207
[TBL] [Abstract][Full Text] [Related]
11. Relevance of tumor boards for the inclusion of patients in oncological clinical trials.
Dapper H; Dantes M; Herschbach P; Algül H; Heinemann V
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7601-7608. PubMed ID: 36995407
[TBL] [Abstract][Full Text] [Related]
12. Virtual Clinical and Precision Medicine Tumor Boards-Cloud-Based Platform-Mediated Implementation of Multidisciplinary Reviews Among Oncology Centers in the COVID-19 Era: Protocol for an Observational Study.
Blasi L; Bordonaro R; Serretta V; Piazza D; Firenze A; Gebbia V
JMIR Res Protoc; 2021 Sep; 10(9):e26220. PubMed ID: 34387553
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of gynecological cancer patients after treatment - the views of European experts in gynecologic oncology.
Vistad I; Cvancarova M; Salvesen HB
Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1286-92. PubMed ID: 22880840
[TBL] [Abstract][Full Text] [Related]
14. Impact of the COVID-19 Pandemic on Diagnosis and Management of Gynecological Cancer: A Single-Center Analysis.
Antunes D; Mendonça L; Melo Â; Gonçalves S; Nogueira Martins F; Nogueira Martins N
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557063
[TBL] [Abstract][Full Text] [Related]
15. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.
Rodriguez-Rodriguez L; Hirshfield KM; Rojas V; DiPaola RS; Gibbon D; Hellmann M; Isani S; Leiser A; Riedlinger GM; Wagreich A; Ali SM; Elvin JA; Miller VA; Ganesan S
Gynecol Oncol; 2016 Apr; 141(1):2-9. PubMed ID: 27016222
[TBL] [Abstract][Full Text] [Related]
16. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
17. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
18. Interprofessional collaboration to improve professional practice and healthcare outcomes.
Reeves S; Pelone F; Harrison R; Goldman J; Zwarenstein M
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD000072. PubMed ID: 28639262
[TBL] [Abstract][Full Text] [Related]
19. Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany.
Chekerov R; Denkert C; Boehmer D; Suesse A; Widing A; Ruhmland B; Giese A; Mustea A; Lichtenegger W; Sehouli J
Int J Gynecol Cancer; 2008; 18(1):1-7. PubMed ID: 17466034
[TBL] [Abstract][Full Text] [Related]
20. Validation of team performance assessment of multidisciplinary tumor boards.
Jalil R; Akhter W; Lamb BW; Taylor C; Harris J; Green JS; Sevdalis N
J Urol; 2014 Sep; 192(3):891-8. PubMed ID: 24631109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
